A study to establish the feasibility and safety of using XR technology to identify tumor location in the lung for sublobar resection.

JRCT ID: jRCT1050240040

Registered date:21/05/2024

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: lung malignant tumor
• Date of first enrollment: 10/11/2023
• Target sample size: 20
• Study type: Observational

Outcome(s)

• Primary Outcome: The difference between the actual distance from the tumor to the margin and the distance from the identified marking point on the extended reality image to the margin.

Secondary Outcome

Duration of surgery
Adverse events

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: < 80age old
• Gender: Both

Include criteria

1. Lung malignant tumor patients who will receive thoracoscopic sublobar resection.
2. The patints with 18 years old or more, and 79 years old or less
3. The patients having provided signed informed consent.
4. The patients who have had blood examination (white blood cells, hemoglobin, platelets, total bilirubin, AST, ALT, serum creatinine, CRP) ,chest X-ray and CT scan of chest with 56 days

Exclude criteria

1. The pregnant patients.
2. The patients with psychiatric disorders or psychiatric symptoms that interfere with daily life and make participation in the study difficult.
3. The patients who are judged to be eligible by investigators.

Related Information

• Primary Sponsor: Tanaka Yugo
• Secondary Sponsor: Tane Shinya